Mitochondrial distribution and activity in human mature oocytes: gonadotropin-releasing hormone agonist versus antagonist for pituitary down-regulation
- PMID: 18367183
- DOI: 10.1016/j.fertnstert.2007.10.042
Mitochondrial distribution and activity in human mature oocytes: gonadotropin-releasing hormone agonist versus antagonist for pituitary down-regulation
Abstract
Objective: To analyze the effects of GnRH agonists versus antagonists on mitochondrial distribution and activity in human mature oocytes.
Design: Randomized research experimental study.
Setting: Academic basic research laboratory and hospital-based fertility center.
Patient(s): Two hundred twenty-five supernumerary mature oocytes from 44 patients.
Intervention(s): Fluorescent staining and confocal laser scanning microscopy on oocytes after the use of either GnRH agonist (group A) or GnRH antagonist (group B).
Main outcome measure(s): Oocyte mitochondrial distribution pattern and activity using MitoTracker Orange CMTM Ros.
Result(s): More oocytes showing polarized mitochondrial distribution pattern were found in group A than in group B (35% vs. 14%). In group B, hCG rather than GnRH agonist, for ovulation induction, resulted in more oocytes showing heterogeneous (57% vs. 14%), in particular polarized (24% vs. 0) mitochondrial distribution. In groups A and B, fluorescence intensity did not vary according to mitochondrial distribution pattern. However, fluorescence intensity was higher in oocytes with polarized and large granules configurations in group B compared to group A.
Conclusion(s): The GnRH agonist and antagonist may have different effects on oocyte mitochondrial distribution pattern and activity. The GnRH antagonist may induce mitochondrial hyperactivity, which may be detrimental to the oocyte.
Similar articles
-
Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.Fertil Steril. 2009 Jun;91(6):2437-44. doi: 10.1016/j.fertnstert.2008.03.057. Epub 2008 Jun 13. Fertil Steril. 2009. PMID: 18555238 Clinical Trial.
-
Comparison of protocols efficacy in poor responders: differences in oocytes/embryos competence with different protocols, a retrospective study.Fertil Steril. 2009 Apr;91(4 Suppl):1431-3. doi: 10.1016/j.fertnstert.2008.06.001. Epub 2008 Aug 15. Fertil Steril. 2009. PMID: 18706554
-
Oocyte maturity and preimplantation development in relation to follicle diameter in gonadotropin-releasing hormone agonist or antagonist treatments.Fertil Steril. 2006 Mar;85(3):578-83. doi: 10.1016/j.fertnstert.2005.08.033. Fertil Steril. 2006. PMID: 16500322
-
How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries.Oncologist. 2007 Sep;12(9):1044-54. doi: 10.1634/theoncologist.12-9-1044. Oncologist. 2007. PMID: 17914074 Review.
-
Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment.Hum Reprod. 2009 Apr;24(4):764-74. doi: 10.1093/humrep/den468. Epub 2009 Jan 19. Hum Reprod. 2009. PMID: 19153090 Review.
Cited by
-
Differences in the Kinetic of the First Meiotic Division and in Active Mitochondrial Distribution between Prepubertal and Adult Oocytes Mirror Differences in their Developmental Competence in a Sheep Model.PLoS One. 2015 Apr 20;10(4):e0124911. doi: 10.1371/journal.pone.0124911. eCollection 2015. PLoS One. 2015. PMID: 25893245 Free PMC article.
-
Observational Study to Assess the Therapeutic Value of Four Ovarian Hyperstimulation Protocols in IVF After Pituitary Suppression with GnRH Antagonists in Normally Responding Women.Clin Med Insights Reprod Health. 2011 Feb 22;5:1-9. doi: 10.4137/CMRH.S6339. eCollection 2011 Feb 22. Clin Med Insights Reprod Health. 2011. PMID: 24453506 Free PMC article.
-
Astaxanthin ameliorates heat stress-induced impairment of blastocyst development in vitro:--astaxanthin colocalization with and action on mitochondria--.J Assist Reprod Genet. 2013 Jun;30(5):623-31. doi: 10.1007/s10815-013-9987-z. Epub 2013 Mar 29. J Assist Reprod Genet. 2013. PMID: 23536152 Free PMC article.
-
GnRH antagonist for patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer in fresh cycles.Exp Ther Med. 2017 Jun;13(6):3097-3102. doi: 10.3892/etm.2017.4309. Epub 2017 Apr 5. Exp Ther Med. 2017. PMID: 28587385 Free PMC article.
-
Resveratrol supplementation during in vitro maturation improves embryo development of prepubertal goat oocytes selected by brilliant cresyl blue staining.J Reprod Dev. 2019 Apr 12;65(2):113-120. doi: 10.1262/jrd.2018-077. Epub 2018 Dec 29. J Reprod Dev. 2019. PMID: 30606957 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources